کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
9182276 | 1182268 | 2005 | 7 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Elección del tratamiento antitrombótico en pacientes con sÃndrome coronario agudo sin elevación del segmento ST de alto riesgo
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
کاردیولوژی و پزشکی قلب و عروق
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Clinical practice guidelines on non-ST-elevation acute coronary syndrome recommend the use of aspirin, heparin, clopidogrel and glycoprotein IIb/IIIa inhibitors in addition to early invasive treatment for high-risk patients. However, no direct evidence is available showing the efficacy, safety, and cost-effectiveness of this strategy. In patients who are at a high risk of experiencing a coronary event and at a low risk of bleeding, it is a reasonable approach. However, a significant percentage of patients do not fulfill both criteria. In these patients, it seems wise to use antithrombotic therapy more cautiously. Here, we review the factors that may influence decision-making in this setting. These may be clinical, such as advanced age, female sex, or a history of diabetes or chronic renal failure, or logistic, such as the practicality of carrying out coronary angiography within 48 hours or of performing surgical coronary revascularization within five days in the absence of an urgent indication.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Revista Española de CardiologÃa Suplementos - Volume 5, Issue 3, 2005, Pages 40C-46C
Journal: Revista Española de CardiologÃa Suplementos - Volume 5, Issue 3, 2005, Pages 40C-46C
نویسندگان
Héctor Bueno,